Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Private health insurance companies in the United States often take their cues from Medicare and Medicaid when it comes to deciding whether or not to cover a certain treatment
CrossRef The transition from NAFLD to MASLD: implications for Diagnosis, Prognosis, and Clinical Management Carlo Acierno, Riccardo Nevola, Fannia Barletta, Katarzyna Zieliska, Luca Rinaldi, Ferdinando Carlo Sasso, Caterina Conte, Luigi Elio Adinolfi, Alfredo Caturano Exploration of Medicine .2025;[Epub] CrossRef The effects of salvia hispanica (chia seeds) on insulin sensitivity, hematological inflammatory indices and liver function in obese patients with non-alcoholic fatty liver disease (NAFLD) Sara Arefhosseini, Maryam Parimi, Helda Tutunchi, Mehrangiz Ebrahimi-Mameghani Nutrition & Metabolism .2025;[Epub] CrossRef Prevalence and Risk Factors of Metabolic DysfunctionAssociated Steatotic Liver Disease in Patients With Type 2 Diabetes Mellitus at a Tertiary Center in Saudi Arabia: Cross-Sectional Questionnaire Study Abdulrahman M Elnasieh, Mohammed Almesned, Akram N Al Hazmi, Atheer Alturki, Faisal I Alhawaidi, Razan K Alhadlq, Maryam Alramadhan, Nasser Alobilan, Yasser Sheikh Qroosh JMIR Diabetes .2025
doi: 10.4321/S1130-01082008001100004 51
Cell Mol Life Sci (2015) 72(2):21736.10.1007/s00018-014-1736-7 34 NguyenATMandardSDrayCDeckertVValetPBesnardPet alLipopolysaccharides-mediated increase in glucose-stimulated insulin secretion: involvement of the GLP-1 pathway
US$ 23.28
US$ 24.80
US$ 27.85
US$ 26.36
US$ 20.48
US$ 21.74
